Benefits/risks of syrup of ipecac
Mofenson, H.C.; Caraccio, T.R.
Pediatrics 77(4): 551-552
1986
ISSN/ISBN: 0031-4005 PMID: 2870465 Document Number: 284548
The status of syrup of ipecac as a nonprescription drug has helped reduce the death rate in children, ages 1 to 5 years. The drug has proven safe and effective in children in the recommended doses. To deprive parents of ready access to ipecac syrup would result in increased disability and death from poisoning and more emergency department visits.